WallStreetZenWallStreetZen

NASDAQ: TRNS
Transcat Inc Stock Forecast, Predictions & Price Target

Analyst price target for TRNS

Based on 2 analysts offering 12 month price targets for Transcat Inc.
Min Forecast
$124.00+12.89%
Avg Forecast
$124.50+13.35%
Max Forecast
$125.00+13.8%

Should I buy or sell TRNS stock?

Based on 2 analysts offering ratings for Transcat Inc.
Buy
Strong Buy
0 analysts 0%
Buy
2 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their TRNS stock forecasts and price targets.

TRNS stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-04-18
lockedlocked$00.00+00.00%2024-04-16

1 of 1

Forecast return on equity

Is TRNS forecast to generate an efficient return?

Forecast return on assets

Is TRNS forecast to generate an efficient return on assets?

TRNS revenue forecast

What is TRNS's revenue in the next 3 years based on estimates from 4 analysts?
Avg 1 year Forecast
$285.7M+13.99%
Avg 2 year Forecast
$289.0M+15.32%
Avg 3 year Forecast
$303.8M+21.21%
TRNS's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

TRNS revenue growth forecast

How is TRNS forecast to perform vs Industrial Distribution companies and vs the US market?
Company
6.37%
Industry
5.93%
Market
9.92%
TRNS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
TRNS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

TRNS vs Industrial Distribution Stocks

TickerPricePrice TargetUp/downsideConsensus
TRNS$109.84$124.50+13.35%Buy
BXC$113.59$144.00+26.77%Strong Buy
DXPE$50.97N/AN/A
TITN$22.61$42.00+85.76%Strong Buy
GIC$40.45N/AN/A

Transcat Stock Forecast FAQ

Is Transcat Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: TRNS) stock is to Buy TRNS stock.

Out of 2 analysts, 0 (0%) are recommending TRNS as a Strong Buy, 2 (100%) are recommending TRNS as a Buy, 0 (0%) are recommending TRNS as a Hold, 0 (0%) are recommending TRNS as a Sell, and 0 (0%) are recommending TRNS as a Strong Sell.

If you're new to stock investing, here's how to buy Transcat stock.

What is TRNS's revenue growth forecast for 2025-2027?

(NASDAQ: TRNS) Transcat's forecast annual revenue growth rate of 6.37% is forecast to beat the US Industrial Distribution industry's average forecast revenue growth rate of 5.93%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.92%.

Transcat's revenue in 2024 is $250,635,000.On average, 4 Wall Street analysts forecast TRNS's revenue for 2025 to be $2,522,569,875, with the lowest TRNS revenue forecast at $2,432,424,489, and the highest TRNS revenue forecast at $2,604,945,630. On average, 1 Wall Street analysts forecast TRNS's revenue for 2026 to be $2,551,882,577, with the lowest TRNS revenue forecast at $2,551,882,577, and the highest TRNS revenue forecast at $2,551,882,577.

In 2027, TRNS is forecast to generate $2,682,200,491 in revenue, with the lowest revenue forecast at $2,682,200,491 and the highest revenue forecast at $2,682,200,491.

What is TRNS's forecast return on assets (ROA) for 2025-2027?

(NASDAQ: TRNS) forecast ROA is N/A, which is lower than the forecast US Industrial Distribution industry average of N/A.

What is TRNS's Price Target?

According to 2 Wall Street analysts that have issued a 1 year TRNS price target, the average TRNS price target is $124.50, with the highest TRNS stock price forecast at $125.00 and the lowest TRNS stock price forecast at $124.00.

On average, Wall Street analysts predict that Transcat's share price could reach $124.50 by Apr 18, 2025. The average Transcat stock price prediction forecasts a potential upside of 13.35% from the current TRNS share price of $109.84.

What is TRNS's forecast return on equity (ROE) for 2025-2027?

(NASDAQ: TRNS) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.